Gain Therapeutics, Inc. (GANX)
NASDAQ·Healthcare·Biotechnology
$1.70
+0.46%
Mkt Cap $82.37M
Analyst Ratings
Buy
1
Hold
0
Sell
0
Price Target (5 analysts)
$9.00
Range $8.00 – $10.00
Implied Upside
+430.1%
Consensus $9.00 vs current $1.70
NASDAQ·Healthcare·Biotechnology
$1.70
+0.46%
Mkt Cap $82.37M
Buy
1
Hold
0
Sell
0
Price Target (5 analysts)
$9.00
Range $8.00 – $10.00
+430.1%
Consensus $9.00 vs current $1.70